Professor J.P. Hong Joins MediThinQ as CMO, Enhancing Digital Microsurgery's Future

MediThinQ Welcomes Professor J.P. Hong as CMO

In a significant development for the field of digital microsurgery, MediThinQ, a rapidly emerging leader in surgical display technology and 3D microscopy, has announced the appointment of Professor Joon-pio Hong as its Chief Medical Officer (CMO). Renowned globally as a foremost authority in reconstructive and super-microsurgery, Prof. Hong’s vast experience is expected to play a crucial role in advancing MediThinQ's pioneering digital microsurgery platform, SHIYA 20.

Prof. Hong is not only the President of the World Society for Reconstructive Microsurgery, but he also holds a professorship at Asan Medical Center in South Korea and serves as an adjunct professor at Georgetown University in the United States. His impressive background in the field includes numerous publications, the training of surgeons across the globe, and a staunch advocacy for technologies that enhance surgical precision and outcomes.

Innovative Technology for Next-Generation Surgery

MediThinQ's SHIYA 20 platform is noted for being among the first fully integrated 3D digital microsurgery systems available. This cutting-edge technology amalgamates visualization, ergonomics, and data capture into a surgeon-centered experience. Prof. Hong’s extensive hands-on experience with SHIYA 20 during live surgeries and through global training sessions has brought forth significant real-world validation for practitioners considering the next evolvement in digital surgical visualization technologies.

Prof. Hong emphasizes, “MediThinQ is shaping the next era of microsurgery. The SHIYA 20 offers a full spectrum of magnification—ranging from low to high (up to 20x)—along with true 3D digital data and genuine ergonomic freedom. This technology provides surgeons with the clarity, comfort, and connectivity we have long sought after. These features are not just conveniences; they are imperative for executing safer and more precise microsurgery.” He expresses excitement about furthering the global impact of this revolutionary platform.

Endorsement from a Respected Leader

Seungjoon Im, the Founder and CEO of MediThinQ, praised Prof. Hong’s decision to join the company, stating, “His involvement underscores the clinical trust we have cultivated within the surgical community. Prof. Hong’s leadership will undoubtedly propel SHIYA 20’s significance in modern microsurgery and guide us in building our digital ecosystem to support surgical treatment and education, as well as future AI-driven innovations.”

SHIYA 20 serves as MediThinQ’s flagship platform, bringing together a 3D digital microscope, 3D exoscope, SCOPEYE wearable visor, and real-time recording into a synchronized workflow that enhances clarity, ergonomics, and efficiency in the operating room. Years of meticulous development alongside surgeons have led to its rise as a new standard in modern microsurgery.

With the technology gaining traction, MediThinQ is gearing up for expanded commercial reach. Recent achievements include securing exclusive distribution partnerships in Taiwan, Singapore, and Malaysia, as well as achieving regulatory approval for their 3D SCOPEYE in mainland China via collaboration with Sinopharm, facilitating widespread access to hospitals nationwide.

A Commitment to Surgical Innovation

MediThinQ, based in South Korea, is committed to transforming surgical environments globally through XR and 3D visualization technologies. With state-of-the-art solutions like SHIYA 20 and SCOPEYE, the company aims to provide organizations with more accurate, ergonomic, and digitally interconnected surgical settings, ultimately enhancing patient care and surgical outcomes.

As MediThinQ continues to embrace its expansion, the partnership with an industry icon like Prof. Hong marks a promising frontier for innovation in surgical technology.